CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Class A Common Stock	Class V Common Stock	Members' Equity	Common Stock Class A Common Stock	Common Stock Class V Common Stock	Retained Earnings / (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Total Stockholders' Equity (Deficit) Attributable to biote Corp.	Non Controlling Interest
Beginning balance, units at Dec. 31, 2020				982,800
Beginning balance at Dec. 31, 2020	$ (17,075,000)						$ (17,052,000)	$ (23,000)	$ (17,075,000)
Distributions	(2,342,000)						(2,342,000)		(2,342,000)
Net income (loss)	8,841,000						8,841,000		8,841,000
Other comprehensive income (loss)	(9,000)							(9,000)	(9,000)
Ending balance, units at Mar. 31, 2021				982,800
Ending balance at Mar. 31, 2021	(10,585,000)						(10,553,000)	(32,000)	(10,585,000)
Beginning balance, units at Dec. 31, 2020				982,800
Beginning balance at Dec. 31, 2020	(17,075,000)						(17,052,000)	(23,000)	(17,075,000)
Net income (loss)	18,602,000
Ending balance, units at Jun. 30, 2021				982,800
Ending balance at Jun. 30, 2021	(6,439,000)						(6,417,000)	(22,000)	(6,439,000)
Beginning balance, units at Mar. 31, 2021				982,800
Beginning balance at Mar. 31, 2021	(10,585,000)						(10,553,000)	(32,000)	(10,585,000)
Distributions	(5,625,000)						(5,625,000)		(5,625,000)
Net income (loss)	9,761,000						9,761,000		9,761,000
Other comprehensive income (loss)	10,000							10,000	10,000
Ending balance, units at Jun. 30, 2021				982,800
Ending balance at Jun. 30, 2021	(6,439,000)						(6,417,000)	(22,000)	(6,439,000)
Beginning balance, units at Dec. 31, 2021				982,800
Beginning balance at Dec. 31, 2021	4,125,000						4,165,000	(40,000)	4,125,000
Distributions	(2,735,000)						(2,735,000)		(2,735,000)
Net income (loss)	9,350,000						9,350,000		9,350,000
Other comprehensive income (loss)	6,000							6,000	6,000
Ending balance, units at Mar. 31, 2022				982,800
Ending balance at Mar. 31, 2022	10,746,000						10,780,000	(34,000)	10,746,000
Beginning balance, units at Dec. 31, 2021				982,800
Beginning balance at Dec. 31, 2021	4,125,000						4,165,000	(40,000)	4,125,000
Net income (loss)	(11,979,000)
Share-based compensation	0
Ending balance at Jun. 30, 2022	(71,312,000)				$ 1,000	$ 5,000	(49,144,000)	(5,000)	(49,143,000)	$ (22,169,000)
Ending balance, shares at Jun. 30, 2022					7,574,271	48,565,824
Beginning balance, units at Mar. 31, 2022				982,800
Beginning balance at Mar. 31, 2022	10,746,000						10,780,000	(34,000)	10,746,000
Net loss through May 26, 2022	(207,000)						(207,000)		(207,000)
Other comprehensive income (loss)	(5,000)							(5,000)	(5,000)
Beginning balance, units at Mar. 31, 2022				982,800
Beginning balance at Mar. 31, 2022	10,746,000						10,780,000	(34,000)	10,746,000
Distributions	(6,840,000)						(6,840,000)		(6,840,000)
Net income (loss)	(21,329,000)
Business Combination: Capitalized transaction costs	(12,282,000)						(12,282,000)		(12,282,000)
Share-based compensation	79,270,000						79,270,000		79,270,000
Settlement of phantom equity rights	(7,250,000)						(7,250,000)		(7,250,000)
Ending balance at Jun. 30, 2022	(71,312,000)				$ 1,000	$ 5,000	(49,144,000)	(5,000)	(49,143,000)	(22,169,000)
Ending balance, shares at Jun. 30, 2022					7,574,271	48,565,824
Business Combination: Reverse recapitalization on May 26, 2022, units				(982,800)
Business Combination: Reverse recapitalization on May 26, 2022	(113,622,000)	$ 1,000	$ 5,000		$ 1,000	$ 5,000	(113,628,000)		(113,622,000)
Business Combination: Reverse recapitalization on May 26, 2022, shares		7,574,271	48,565,824		7,574,271	48,565,824
Business Combination: Noncontrolling interest on May 26, 2022							3,619,000	34,000	3,653,000	(3,653,000)
Net income (loss)	(21,122,000)						(2,606,000)		(2,606,000)	(18,516,000)
Ending balance at Jun. 30, 2022	$ (71,312,000)				$ 1,000	$ 5,000	$ (49,144,000)	$ (5,000)	$ (49,143,000)	$ (22,169,000)
Ending balance, shares at Jun. 30, 2022					7,574,271	48,565,824